News

Three takeaways from Stat's interview with the Senate Finance Committee chairman.

A wave of new business is attempting to shake up, improve primary care.

Two studies in JAMA produce meh results for polygenic risk scores

Treatments include meds for arthritis pain and allergy eye drops.

Treatment will be first to target a specific type of advanced lung cancer.

V-Sensor- and e-Checkup-enabled smartphones measure temperature, blood pressure, respiration and other vital signs to medical accuracy.

Michael Bloomberg wants a Medicare-like public insurance option, not Medicare for all. It's what you'd expect from a candidate who is appealing for support from moderate Democrats.

2020 wellness survey finds employees want more health programs, but few employers are offering them.

Health professionals are sharing what healthcare is becoming and what they believe it will become in the future.

Trump administration hints that it may agree and is considering a broader scope of practice for nurse practitioners and physicians.

Data security is just one part of it. Payers also need to deliver an excellent member experience to create and maintain trust.

Twenty percent of seven in-network elective surgeries for a large national insurer resulted in a “surprise” out-of-network bill; averaging at $2,011.

FDA cleared the first generic sodium iodide product to treat hyperthyroidism and carcinoma of the thyroid.

Here’s a look at what payers and providers can expect to occur, why each change is occurring, and how payers and providers can prepare for each change.

FDA's Center for Drug Evaluation and Research approved fewer new treatments in 2019.

Top thought leaders share their favorite non-business reads.

Managed Healthcare Executive surveyed hundreds of healthcare leaders and professionals to collect information on how their organizations are affected by technology. This year’s survey displays data focusing on healthcare organizations’ current status, patient access, data collection, communication, and future with technology.

Healthcare professionals share the investments’ health organizations are making and why.

More consumers are purchasing short-term limited duration insurance plans-which will likely have long-lasting effects to consumers and the insurance market as a whole.

Employer-sponsored insurance keeps many working.

How cancer patients can better organize around their cancer care plans in a more redesigned system.

A new study on a controversial drug shows the scientists who first found a conection with heart attacks and death were possibly right.

The top technologies for 2020 aren’t new, but they are on the cusp of moving into broader use in healthcare.

Ranks have swelled between 2010 and 2017 partly because of access to online learning.

The first FDA-approved product for NASH on the horizon.

Global market for peanut allergy treatments estimate at $4.5 billion.

A new class of drugs for high cholesterol and a novel peanut allergy treatment lead expected approvals.

How pharmacies should adopt value- and performance-based payment models and offer DIR fee reductions for pharmacists’ and their patients’ benefit.